ASX:IMMPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Immutep Ltd
$0.057
Day Range
$0.055 – $0.058
52 Week Range
$0.028 – $0.470
Volume
0.00
Avg Volume (10D)
14.41M
Market Cap
$84.00M
Price Chart
Market Statistics
Open$0.057
Previous Close$0.057
Day High$0.058
Day Low$0.055
52 Week High$0.470
52 Week Low$0.028
Valuation
Market Cap84.00M
Shares Outstanding1.47B
Price to Book0.82
Trading Activity
Volume0.00
Value Traded0.00
Bid$0.058 × 17
Ask$0.055 × 90,909
Performance
1 Day-1.79%
5 Day0.00%
13 Week41.03%
52 Week-77.55%
YTD-86.75%
Technical Indicators
RSI (14)56.87
50-Day SMA$0.054
200-Day SMA$0.219
Latest News
Hot Topics
Weekly Wrap: Shares fall another 2.6% for the week as conflict worsens
ASX 200 slides 2.6% this week to 8,617 as Iran-Israel conflict lifts oil above $100; NST and SYR plunge, while EOS soars on a Middle East contract.
Biotechnology
Immutep doses first patient in Phase II/III efti trial to treat metastatic breast cancer
Biotechnology company Immutep (ASX: IMM) has safely dosed the first patient at a European clinical site for its integrated Phase II/III AIPAC-003 trial to treat metastatic breast cancer. AIPAC-003 is evaluating the company’s soluble LAG-3 protein and first-in-class MHC Class II agonist known as eftilagimod alpha (efti) in combination with standard-of-care paclitaxel for the treatment […]